Medical Device & Pharmaceutical Regulatory Consulting in South Korea | GRP

Committed to your success, from Concept to Approval.

Medical Device and Pharmaceuticals Regulatory Affairs and Quality Consulting for South Korea

South Korea Regulatory Affairs

Upcoming Events

  1. Bio International Convention 2018

    June 4, 2018 - June 7, 2018
  2. Biotech Japan

    June 27, 2018 - June 28, 2018

GRP provides Regulatory, Clinical and Compliance services across the globe

North America
Latin America
Asia
European Union
Australia

Choose the Country

Learn more about how we can assist you with Regulatory, Clinical and Compliance services in your country of interest

MARKET OVERVIEW

South Korea’s healthcare market is ranked fourth among countries in the Asia-Pacific region. The combination of increased insurance coverage, an aging population, and government initiatives to expand the healthcare market make South Korea a prime destination for foreign medical companies looking to go abroad. GRP team can help your medical device company access the Korean medical market by registering successfully your products in Korea.

South Korea Medical Device Market Size South Korea Pharmaceutical Market Size
 $5.5 billion $22 billion
Projected Growth Rate: 5.3% Projected Growth Rate: 4%
South Korea Economic Indicators
GDP (PPP): $1.8 trillion
Per Capita GDP (PPP): $36,500
Real GDP Growth Rate: 2.7%
Population (millions): 50.5
Ethnic Diversity: 92% Very Homogenous

REGULATORY AUTHORITY

The Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA), oversees the safety and efficacy of drugs and medical devices in Korea.

The MFDS is divided into five bureaus. The Pharmaceutical Safety Bureau and the Medical Device Safety Bureau are the two divisions holding primary responsibility for pharmaceutical and medical device regulations. For more information check MFDS (KFDA) website at: http://www.mohw.go.kr/eng/